Skip to main content
 
 

Getting ready to finish cancer treatment and want to know what is next? Finished cancer treatment and want to be sure you know what you should be doing for follow-up? A Survivorship Care Plan can help.

What’s a care plan? It’s a roadmap to guide your cancer care following your diagnosis and treatment of cancer. People who have completed treatment of melanoma or are currently in treatment can develop a care plan with their health care team. A care plan can:

  • Detail your diagnosis,
  • Outline the treatments you have had or are currently taking,
  • Tell you who on your health care team to contact with questions or concerns,
  • Explain symptoms or side effects you might experience and who to call if you need help managing them, and
  • Outline what you should do and who you should see for follow-up care.

Watch the webinar, Frankly Speaking About Cancer: Survivorship Care Planning that took place on August 30, 2016, for information on survivorship care planning. This webinar shows from a social worker and a survivor’s point of view. The presentation is followed by a question and answer period with the speakers. This webinar uses a Melanoma Survivorship Care Plan, as well as a generic Cancer Survivorship Care Plan, so it will be of special interest to melanoma survivors. Survivorship care planning is a great step for survivors and caregivers who are about to finish active treatment of their cancer.

The webinar features the following panelists:

  • Rosie Morrison, LLMSW, Program Director at the Cancer Support Community of Greater Ann Arbor
  • Donna Piunt, Melanoma Survivor
  • Kim Ziner, PhD, RN, CBCN, ACNS-BC, Clinical Nurse Specialist at Franciscan St. Francis Health, Indianapolis, IN

Resources

Survivorship Care Planning Webinar

Survivorship Care Planning Webinar

View

The webinar will be run through CiscoWebEx with a slide presentation. After the panelists‘ presentations, participants will have the opportunity to ask questions through a chat feature during the Q&A session.

This program is made possible by a charitable grant from Bristol-Myers Squibb